Guidance on Antiviral Drug Use during an Influenza Pandemic
GUIDANCE NOTES
Guidance from the literature: Multiple Sclerosis
Guidance for working Royal College of General Practitioners
Guidance for the use of lithium in South West Yorkshire Partnership
Guidance for the use and reduction of misuse of benzodiazepines
Guidance for the Safe Use of Cytotoxic Chemotherapy in Grampian
Guidance for the prevention, testing, treatment and management of
Guidance for the Prescribing of Subcutaneous Furosemide by Bolus
Guidance for the pharmacological management of substance
Guidance for the management of influenza
Guidance for the Ethical Allocation of Scarce Resources During a
Guidance for Staff on Medicines used to Treat Common Conditions
Guidance for Spinal Cord Injury patients prior to admission
Guidance for Physicians On Assessment of Medical Fitness to Use
Guidance for Patients with Suspect or Confirmed Viral
Guidance for national tuberculosis programmes on the m anagement of tuberculosis in children
Guidance for national tuberculosis programmes on the
Guidance for Industry Pulmonary Tuberculosis: Developing Drugs for Treatment
Guidance for Industry Influenza: Developing Drugs for Treatment and/or Prophylaxis
